Pfizer to give US another 100 million doses of COVID-19 vaccine
Pfizer and BioNTech will supply the U.S. with an additional 100 million doses of the COVID-19 vaccine under a new agreement.
Canadian health officials approve Pfizer's COVID-19 vaccine
Canadian health officials on Wednesday approved Pfizer’s COVID-19 vaccine, days ahead of possible approval in the United States.
FDA to decide on full approval of Pfizer COVID-19 vaccine by January
Pfizer is seeking to have its COVID-19 shot become the first fully approved vaccine against the novel coronavirus.
Pfizer omicron vaccine: Company begins studying updated shot to match variant
Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant.
FDA panel endorses Pfizer’s COVID-19 vaccine for children 5-11
An FDA panel of outside vaccine experts endorsed kid-sized doses of Pfizer’s COVID-19 vaccine for U.S. children aged 5 to 11.
FDA authorizes Pfizer COVID-19 vaccine for kids ages 12 to 15
The FDA on Monday cleared Pfizer’s COVID-19 vaccine for kids ages 12 to 15 for emergency use.
Canada authorizes Pfizer COVID-19 vaccine for ages 12 to 16
Canadian health officials said Wednesday they have become the first to approve Pfizer’s COVID-19 vaccine for ages as young as 12.
Pfizer identifies fake COVID-19 vaccine doses in Mexico, Poland
Pfizer confirmed it found fake versions of its COVID-19 vaccine in both Mexico and Poland. The company emphasized that legitimate vaccines are never sold online.
US negotiating with Pfizer for millions more doses of COVID-19 vaccine
The U.S. government is negotiating with Pfizer to acquire tens of millions of additional vaccine doses in exchange for helping the pharmaceutical giant gain better access to manufacturing supplies.
Pfizer seeks FDA authorization of COVID-19 vaccine for kids 5 to 11
Pfizer has formally submitted a request to the FDA for emergency authorization of its COVID-19 vaccine for children ages 5 to 11.